Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference
AUSTIN, TX and DURHAM, NC, Feb. 09, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology…
Pharmaceuticals, Biotechnology and Life Sciences
AUSTIN, TX and DURHAM, NC, Feb. 09, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology…
The Company has also Executed a Share Purchase Agreement to Acquire up to 34% of a Cannabis Retail-Focused Technology Venture…
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., chief…
FOURTH QUARTER IN BRIEF In 2021, we made substantial progress in our projects to address unmet medical need in hematological…
Monthly information regarding the total number of voting rights andtotal number of shares of the Company as of January 31,…
SEATTLE, Feb. 09, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development…
PHILADELPHIA, Feb. 09, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell…
Precomplexing NK cells with Innate Cell Engagers (ICEĀ® molecules) results in a CAR-like NK cell product, whose magnitude and specificity…
Topline results from RZ358 Phase 2b and RZ402 Phase 1b studies expected before the end of Q1 2022REDWOOD CITY, Calif.,…
MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at…